Search

everythinglearnresearchcommunity

for

Search:↓

Stopping certain drugs can improve skin conditions, arsenicosis affects over half of a Bangladeshi village, males are more vulnerable, and certain treatments are effective for warts, acne, and psoriasis. Smoking and drinking are linked to psoriasis in men, a cream helps with a type of skin cancer, and low iron levels don't directly cause chronic hair loss in women.

High blood pressure drugs often cause skin lupus, stopping the drug usually helps. A vaccine helps prevent genital herpes and HPV-16. More frequent light therapy clears psoriasis faster. No link was found between low iron and chronic hair loss.

Treating psoriasis with UVB light three times a week is faster than twice a week, and certain medications and lifestyle factors affect psoriasis treatment outcomes.

Skin problems are common in Bangladesh due to arsenic, prompt treatment of diabetic foot ulcers is crucial, maternal transmission causes most neonatal herpes, treatments for pediatric vasculitis are effective, the chickenpox vaccine works, more frequent UVB therapy helps psoriasis, certain jobs increase hand dermatitis risk, monoclonal antibodies treat psoriasis well, lifestyle affects psoriasis, alefacept improves psoriasis, imiquimod cream partially clears basal cell carcinoma, and iron may not help chronic hair loss.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Men with androgenetic alopecia have oilier and less hydrated scalps, especially in sensitive areas.

Dandruff is a common, winter-worsened scalp condition linked to inflammation and microorganisms, treatable with products like ketoconazole, and may affect hair loss.

Hair loss in men is common, treatable, but not curable.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Some newly made compounds can block an enzyme linked to hair loss and prostate growth, with one in particular being very selective.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

The document says biodegradable cosmetics and packaging are better for the environment and user experience.

Thyrotropin-Releasing Hormone helps heal wounds in frog and human skin.

Treating hair loss requires a comprehensive approach that addresses both physical and emotional aspects, with a focus on diagnosis, patient education, and good communication.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Acne is significantly influenced by genetics, and understanding its genetic basis could lead to better, targeted treatments.

Certain fats in the skin help control inflammation and health, and changing these fats through diet or supplements might treat skin inflammation.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Androgens may block hair growth signals, targeting this could treat hair loss.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

The study found that the average age of women diagnosed with Frontal Fibrosing Alopecia in Argentina is higher than in other countries, but their symptoms are similar.

Keratin genes change gradually during skin cell development and should be used carefully as biomarkers.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.

The research found genes that change during cashmere goat hair growth and could help determine the best time to harvest cashmere.

Ptprq has multiple forms that change during inner ear development.

Advanced male pattern baldness affects the back of the scalp, reducing hair follicles.

TPA is about 50 times more effective at promoting tumors than MZ.

Dutasteride more effectively lowers DHT levels in men with enlarged prostates than finasteride.

Hair mineral analysis might help diagnose diseases early, but standard methods are needed.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.